key: cord-0717768-ci4wu9wa
authors: Chaijaras, Sasipim; Seree-aphinan, Chutima; Rutnin, Suthinee; Ngamjanyaporn, Pintip; Rattanakaemakorn, Ploysyne
title: Serum sickness-like reaction following an administration of the first dose of inactivated COVID19 vaccine: a case report.
date: 2021-11-11
journal: JAAD Case Rep
DOI: 10.1016/j.jdcr.2021.11.004
sha: 1bdbb58511e9d364968e98c73906bcef28169640
doc_id: 717768
cord_uid: ci4wu9wa

nan

and several other countries. It has been considered relatively safe, with the most commonly 8 encountered side effects being injection site reactions, fever, fatigue, diarrhea, and muscle pain 1 . 9 Regarding cutaneous side effects, discoloration at the injection site and pruritus have been reported 10 from vaccine trials. 1 Herein, we present a case of a severe adverse reaction to the inactivated 

SARS-CoV-2 vaccine in healthy adults aged 18-59 years: a randomised, double-blind, placebo-107 controlled, phase 1/2 clinical trial. The Lancet Infectious Diseases

Immune complex-like disease 110 in 23 persons following a booster dose of rabies human diploid cell vaccine. Vaccine

Serum sickness and Hepatitis B vaccine including review of the literature

Serum sickness-like reaction 115 associated with inactivated influenza vaccination among Thai Health Care Personnel: Risk 116 factors and outcomes. Article

Cutaneous drug eruptions including serum sickness-119 like reaction, symmetrical drug-related intertriginous and flexural exanthema, and drug-induced 120 lupus. Article

Severe Delayed Cutaneous and Systemic Reactions to 123

Drugs: A Global Perspective on the Science and Art of Current Practice

Serum sickness-like drug reaction: two cases with a neutrophilic 129 urticarial pattern. Article

Serum sickness-like reaction: Histopathology and case 132 report

A rapid desensitization protocol in a case of 135 drotaverine-induced serum sickness-like reaction in a pregnant woman: A case report

Experimental and Therapeutic Medicine